538.10
-4.38
(-0.81%)
At close: January 29 at 4:00:01 PM EST
537.75
-0.35
(-0.07%)
Pre-Market: 9:16:34 AM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 22 | 22 | 27 | 27 |
| Avg. Estimate | 7.29 | 7.49 | 29.77 | 33.55 |
| Low Estimate | 5.89 | 7.22 | 29.38 | 32.02 |
| High Estimate | 7.91 | 8.24 | 30.22 | 34.29 |
| Year Ago EPS | 6.91 | 6.8 | 27.66 | 29.77 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 17 | 16 | 22 | 23 |
| Avg. Estimate | 111.64B | 112.46B | 452.34B | 485.61B |
| Low Estimate | 109.26B | 110.63B | 441.88B | 462.74B |
| High Estimate | 113.91B | 113.54B | 457.42B | 498.6B |
| Year Ago Sales | 99.8B | 98.86B | 400.28B | 452.34B |
| Sales Growth (year/est) | 11.86% | 13.76% | 13.01% | 7.35% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | 6.62 | 6.63 | 7.03 | 6.74 |
| EPS Actual | 6.91 | 6.8 | 7.15 | 6.81 |
| Difference | 0.29 | 0.17 | 0.12 | 0.07 |
| Surprise % | 4.44% | 2.49% | 1.70% | 1.08% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 7.29 | 7.49 | 29.77 | 33.55 |
| 7 Days Ago | 7.32 | 7.5 | 29.77 | 33.52 |
| 30 Days Ago | 7.31 | 7.33 | 29.83 | 33.73 |
| 60 Days Ago | 7.38 | 7.35 | 29.93 | 33.84 |
| 90 Days Ago | 7.42 | 7.41 | 30.12 | 34.08 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 7 | 12 | -- | 3 |
| Up Last 30 Days | 9 | 13 | 1 | 3 |
| Down Last 7 Days | 9 | 4 | 11 | 9 |
| Down Last 30 Days | 9 | 5 | 12 | 11 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| UNH | 5.57% | 10.21% | 7.64% | 12.68% |
| S&P 500 | 9.01% | 10.57% | 14.00% | 13.70% |
Upgrades & Downgrades
| Maintains | Wells Fargo: Overweight to Overweight | 1/28/2025 |
| Maintains | Barclays: Overweight to Overweight | 1/17/2025 |
| Reiterates | Keybanc: Overweight to Overweight | 1/17/2025 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 1/17/2025 |
| Maintains | Truist Securities: Buy to Buy | 1/6/2025 |
| Maintains | Piper Sandler: Overweight to Overweight | 1/2/2025 |
Related Tickers
ELV Elevance Health, Inc.
400.30
-1.26%
HUM Humana Inc.
294.23
-2.93%
CVS CVS Health Corporation
56.90
-0.75%
CI The Cigna Group
303.31
+0.16%
CLOV Clover Health Investments, Corp.
4.4500
-3.05%
CNC Centene Corporation
63.91
-1.25%
OSCR Oscar Health, Inc.
16.68
+2.46%
MOH Molina Healthcare, Inc.
304.28
-1.02%
ALHC Alignment Healthcare, Inc.
15.32
+0.66%
NEUE NeueHealth, Inc.
7.34
-0.14%